Patents/Inventors

Barbra Johnson Sasu

San Francisco, CAUS17 patents

16 Patents

US126066232026
DLL3 Targeting Chimeric Antigen Receptors and Binding Agents
PFIZER Inc.
0 cites
US125288562026
Chimeric Cytokine Receptors Comprising TGF Β Binding Domains
Allogene Therapeutics, Inc.
0 cites
US124471782025
Method of Treatment Using Anti-cd19 Rituximab-resistant Chimeric Antigen Receptors
Allogene Therapeutics, Inc.
0 cites
US124043152025
Protease-activating Cd45-gate CAR
Pfizer Inc.
0 cites
US122960122025
Chimeric Antigen Receptors Targeting FLT3
PFIZER Inc.
0 cites
US122153472025
Chimeric Antigen Receptors with Enhanced Signaling and Activities and Uses Thereof
Allogene Therapeutics, Inc.
0 cites
US121631532024
Methods of Manufacturing Allogeneic CAR T Cells
Allogene Therapeutics, Inc.
0 cites
US120436552024
Constitutively Active Chimeric Cytokine Receptors
Allogene Therapeutics, Inc.
0 cites
US120362432024
BCMA CAR-T Cells with Enhanced Activities
Allogene Therapeutics, Inc.
0 cites
US119876342024
Antibodies Specific for CD70 and Their Uses
PFIZER Inc.
0 cites
US119127762024
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
PFIZER Inc.
0 cites
US118966172024
Polynucleotides Encoding Rituximab-resistant Chimeric Antigen Receptors
ALLOGENE THERAPEUTICS, Inc.
0 cites
US117865532023
Chimeric Cytokine Receptors Bearing a PD-1 Ectodomain
ALLOGENE THERAPEUCTICS, Inc.
0 cites
US117812482023
Anti-talen Antibodies and Uses Thereof
ALLOGENE THERAPEUTICS, Inc.
0 cites
US117320412023
Antibodies Against 4g7-derived Chimeric Antigen Receptors
ALLOGENE THERAPEUTICS, Inc.
0 cites
US116739532023
DLL3 Targeting Chimeric Antigen Receptors and Binding Agents
PFIZER Inc.
0 cites